Table 2.

Survival outcomes of patients with IPMN and MCN.

Outcomes		IPMN (n = 2,300)	MCN (n = 205)	P-value
Overall survival	1 year	46.3%	69.9%	P < 0.001
	3 year	22.2%	49.7%	P < 0.001
	5 year	16.6%	45.3%	P < 0.001
	Median	11 months	36 months	P < 0.001
Cancer-specific survival	1 year	48.3%	73.6%	P < 0.001
	3 year	24.2%	55.2%	P < 0.001
	5 year	19.3%	52.4%	P < 0.001
	Median	12 months	111 months	P < 0.001

IPMN, intraductal papillary mucinous neoplasm; MCN, mucinous cystic neoplasm.